Found 32 matching trials
Mechanistic Randomized Controlled Trial (RCT) of Mesalazine in Symptomatic Diverticular Disease
NADiverticulosis (bulges in the bowel wall) affects two third of the elderly ...
Location
NIHR Biomedical Research Unit, Nottingham University Hospital
Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis
PHASE3To demonstrate that import Mesalazine (Asacol®) is non-inferior to the refe...
Location
Shanghai Hospital
Asacol Acute Diverticulitis(DIVA)Study
PHASE2The purpose of this study is to determine whether Asacol® 2.4 g/day (400 mg...
PRObiotic VSL#3® for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitis
NAUlcerative colitis (UC) is an inflammatory bowel disease (IBD) characterize...
Location
Istituto di Medicina Interna CIC Columbus Policlinico Universitario Agostino Gemelli Università Cattolica del Sacro Cuore
Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis
PHASE3The purpose of this study is to determine whether low dose Asacol® (27 mg/k...
Palmitoylethanolamide in Ulcerative Colitis
NAEvaluate the effects of PEA supplementation on disease activity, health-rel...
Location
Internal Medicine and Gastroenterology clinic, El-Demerdash Hospital
An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase
PHASE3The purpose of this study is to investigate the efficacy and safety of 4-we...
Location
The 6th hospital affiliated to Zhongshan University (there may be other sites in this country)
Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis
PHASE3To establish the efficacy and safety of a new tablet formulation and dosing...
Location
Premiere Pharmaceutical Research
Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase
PHASE3To demonstrate that import Mesalazine (ASACOL®) is non-inferior to the refe...
Location
Shanghai Hospital
Study of Pentasa® for Reducing Residual Systemic Immune Activation in Treated HIV Infection
PHASE1An open label study will be performed on 80 people with HIV infection who a...
Location
AIDS Healthcare Foundation - Public Health Division